Pranava Sinha, MD – a key partner of Dr. Craig Sable and Heart Healers International – has been awarded a grant through Children's National Hospital for a heart surgery mission trip to Uganda for this September.

This month our founder Dr. Craig Sable appeared on the Colony Group's podcast, 'Seeking the Extraordinary' with Michael Nathanson.

A new presidential advisory from the American Heart Association that includes Dr. Sable as an author, provides new insights into very rare, but serious adverse reactions to Penicillin in patients with rheumatic heart disease.

The paper, based on a registry of over 600 children in Uganda who had symptoms of RHD, is some of the most compelling data we’ve ever published that captures the extreme severity of RHD.

The paper provides a follow-up to previous studies published in 2017 and 2019 and tracks a significant disparity between CHD mortality in high income and low income countries.

Heart Healers International is proud to be a part of a new study about Rheumatic Heart Disease (RHD), published today in The New England Journal of Medicine. The study proves that penicillin works to prevent the progression of early echo detected RHD. RHD affects 40.5 million people globally and results in over 306,000 annual deaths

“We are excited to share an inspirational story about a medical team from the United States and Uganda who bonded together during this uncertain time to treat patients with heart disease and to continue building a sustainable heart surgery program in Uganda.”

“This publication on Global Burden of Congenital Heart Disease will help change the conversation about the impact of CHD globally – highlighting the substantial loss of life to CHD in infancy around the globe.”

“Heart Healers helped to place over 100 Ugandan children with congenital heart disease for successful heart surgery in India, the United States and Grand Cayman in the last three years with additional support from Samaritan’s Purse Children’s Heart Project and Gift of Life International. “

“This study provides more detail than ever before about the global impact of RHD,” explains Dr. Sable. “It utilizes global burden of disease tools that are updated on an annual basis. These tools are considered highly reputable and allow for ongoing tracking and comparison to other diseases.”

“Over the next four years, the Rheumatic Heart Disease Center, led by Children’s National Heart Institute experts Dr. Sable and Andrea Beaton, M.D., cardiologist, along with RHD leaders around the globe, will develop evidence-based strategies to strengthen the health system’s response to RHD through synergistic basic, clinical and population science research along the entire spectrum of the disease.”